LKLyudmila K. Karazhanova

Lyudmila K. Karazhanova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lyudmila K. Karazhanova has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cluster Analysis in Phenotyping Patients with Severe Bronchial Asthma

    by S. Yu. Maimysheva, L. K. Karazhanova, A. A. Chinybaeva, A. Yu. Orekhov

    One in 10 patients with asthma suffers from severe asthma, which is characterized by the presence of several clinical phenotypes. The aim of the study is to identify the clinical phenotypes of patients with difficult-to-control and severe asthma based on cluster analysis. Materials and Methods: A cross-sectional study was conducted, including 200 patients with difficult-to-control asthma. Inclusion criteria: severe and difficult-to-control asthma, all patients received treatment according to the 4th-5th step of the provided guidelines (GINA); age over 18 years. Exclusion criteria: the presence of chronic obstructive pulmonary disease, active infectious diseases, including respiratory infections, oncological diseases, pregnancy. All patients underwent clinical and laboratory tests, and levels of leptin, adiponectin, IL-6, IL-8, IL-4, and TNF-α were measured. To phenotype patients with severe asthma, cluster analysis was performed. Statistical data processing was conducted using SPSS Statistics 20.0 and StatTech v. 4.7.2 (StatTech, Russia). Results: The study included 200 patients with difficult-to-control asthma, with a median age of 53.5 (39.0-59.25) years. As a result of the cluster analysis using the k-means method, 3 clusters were identified. Significant differences were found in BMI, eosinophil count, IgE levels, and leptin (p < 0.001 when comparing the 3 clusters). Differences were also found in the levels of pro-inflammatory cytokines, primarily IL-4 (p=0.003 for the 3 clusters), TNF-α, and IL-8 (p < 0.001 when comparing the 3 clusters). It was established that the development of hypereosinophilia in patients with difficult-to-control asthma may be mediated not only by the IL-4 level (1.326, 95 % CI 1.132-1.554), but also by TNF-α (OR 1.046, 95 % CI 1.022-1.07) and IL-8 (OR 1.054, 95 % CI 1.024-1.085). Conclusion: We identified 3 clusters of patients with difficult-to-control bronchial asthma based on the study of clinical, laboratory, and instrumental data. Each identified cluster is characterized by a specific combination of laboratory markers, which can be taken into account when further treating patients with this asthma phenotype.

  • Open Access

    Klotho: Potential Marker of High Cardiovascular Risk in Patients With Acute Coronary Syndrome and Chronic Kidney Disease

    by Aisulu S. Zhunuspekova, Andrey Yu. Orekhov, Jamilya A. Mansurova, Assel A. Chinybaeva, Lyudmila K. Karazhanova

    Aim: Recently it was established that the deficit of Klotho morphogenetic protein in serum is one of the most likely predictors of cardiovascular mortality. Purpose of the Study: to examine the association of Klotho with adverse prognosis factors in patients with acute non-ST-segment elevation myocardial infarction and chronic kidney disease. Materials and Methods of the Study: The analysis included patients with acute myocardial infarction without ST-segment elevation and chronic kidney disease. Inclusion criteria: AMI without persistent ST-segment elevation that underwent coronary artery stenting after coronary angiography; presence of chronic kidney disease diagnosed as a decrease in glomerular filtration rate less than 60 ml/min/1.73m2. Exclusion criteria: terminal CKD or patients on program hemodialysis, presence of acute kidney injury, cancer, refusal to participate in the study. Results: Initial analysis showed that decreased Klotho levels were common among elderly patients, and among these patients there was more frequent history of myocardial revascularization, as well as a higher risk of adverse events according to the GRACE scale. The association of Klotho level with three cardiovascular complications risk factors—age (β = −9.884 (SD 1.667), p = 0.000), C-reactive protein level (β = −0.661 (SD 0.205), p = 0.002) and troponin (β = −0.07 (SD 0.031), p = 0.026)—was determined by multiple linear regression method. Conclusion: The prospective study demonstrated that Klotho may act as one of the markers of cardiovascular risk in patients with non-ST elevation myocardial infarction and chronic kidney disease. Its independent association with three risk factors of cardiovascular risk – age, C-reactive protein level and troponin was established.

  • Open Access

    КЛИНИКО-ФУНКЦИОНАЛЬНЫЕ ОСОБЕННОСТИ БРОНХИАЛЬНОЙ АСТМЫ В СОЧЕТАНИИ С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ

    by Маймышева С.ю., Каражанова Л.к., Орехов А.ю., Чиныбаева А.а., Аширов Б.а., Танышева Г.а.

    Введение: Бронхиальная астма (БА) является распространенным хроническим неинфекционным заболеванием дыхательных путей. Одним из клинических фенотипов является ее сочетание с метаболическим синдромом (МС). Такая форма синтропии приводит к более тяжелому течению заболевания и плохому прогнозу, часто являясь причиной тяжелой и трудноконтролируемой формы астмы. Цель исследования: изучить клинический фенотип пациентов тяжелой БА в сочетании с МС. Материалы и методы: В настоящее исследование включено 200 пациентов с тяжелой и плохо контролируемой БА, ассоциированной с МС. Критерии включения в исследование: тяжелая и плохо контролируемая бронхиальная астма, диагноз которой соответствовал международным критериям GINA, возраст старше 18 лет. Критерии исключения: курение, наличие хронической обструктивной болезни легких, активное инфекционное заболевание, в том числе инфекции респираторной системы, онкологические заболевания, беременность. Во время госпитализации в отделение пульмонологии всем пациентам проводились клинико-лабораторные и инструментальные исследования (рентгенография органов грудной клетки и, по показаниям, мультиспиральная компьютерная томография легких, спирометрия). Результаты: В исследовании в основную группу (в сочетании с МС) включено 112 (56%) пациентов, в контрольную (без МС) - 88 (44%) пациентов. Все пациенты имель плохой контроль БА, при этом среди пациентов с МС (основная группа) отмечался значимо худший контроль астмы (Ме АСТ-теста составила 11), различия были значимыми (р<0,001). По данным спирометрии установлено, что в основной группе отмечался меньший уровень ФЖЕЛ и ОФВ1. Также установлено, что наличие гиперэозинофилии ассоциировано со снижением ОФВ1 (ОШ 0,82) и ПСВ после бронходилатационного теста (ОШ 0,988). Выводы: Выявленные в исследовании изменения функции внешнего дыхания у пациентов с тяжелой БА в синтропии с МС, определяемое в снижении ОФВ1, ФЖЕЛ и соотношения ОФВ1 и ФЖЕЛ, необходимо учитывать при лечении данного фенотипа БА. Комплексный подход, основанный на применении всех фармакологических возможностей в сочетании с коррекцией ИМТ, вероятно, является фактором улучшения функции легких, тем самым повышая степень контроля симптомов БА. Introduction: Asthma is a common chronic non-communicable respiratory disease. One of its clinical phenotypes includes combination with metabolic syndrome. This form of syntrophy results in a more severe course of the disease and a poor prognosis of the disease, often causing severe and poorly controlled form of the asthma. Aim: To study the clinical phenotype of the patients with severe form of asthma combined with metabolic syndrome. Materials and methods: 200 patients with severe and poorly controlled asthma associated with metabolic syndrome were included in this study. Study inclusion criteria were severe and poorly controlled asthma diagnosed according to the GINA international criteria, age over 18 years. Study exclusion criteria were smoking, having chronic obstructive pulmonary disease, active infection, including respiratory system infections, cancer, pregnancy. All the patients underwent clinical and laboratory, instrumental examinations (chest X-ray examination and, according to the indications, multispiral computed tomography of the lungs, spirometry) while hospitalized in the Pulmonology Department. Results: 112 (56%) patients were included in the study group (combined with MS), 88 (44%) patients were included in the control group (without MS). All the patients had poor control of asthma, meanwhile patients with MS (study group) were indicated with significantly worse asthma control (AST-test Me was 11), differences were significant (р<0,001). According to spirometry it was indicated that study group had lower level of FVC and FEV1. It was also stated that having hypereosinophilia was associated with lower FEV1 (OR 0.82) and PEF after bronchodilatatory test (OR 0.988). Conclusion: The identified during the study changes in external respiratory function in patients with severe asthma in syntrophy with MS, as determined by a decrease in EFV1, FVC and the ratio of FEV1 to FVC, should be taken into account in the treatment of...

  • Open Access

    PATHOPHYSIOLOGICAL AND CLINICAL CORRELATIONS BETWEEN BRONCHIAL ASTHMA AND METABOLIC SYNDROME: A REVIEW

    by Maimysheva S.YU., Karazhanova L.K., Orekhov A.YU., Chinybaeva A.A., Ashirov B.A.

    Introduction: Bronchial asthma (BA) and obesity represent significant challenges in contemporary medicine, with escalating prevalence in developed nations. This review aims to systematically analyze the pathophysiological and clinical interplay between bronchial asthma and metabolic syndrome, emphasizing their role in severe asthma development. Search strategy: A thorough literature search was conducted up to May 10, 2024, using PubMed, Web of Science, and the Cochrane Central Register of Controlled Trials. The search spanned the past decade and employed predefined keywords based on Medical Subject Headings (MeSH). Inclusion criteria encompassed studies meeting evidence-based medicine standards and fundamental experimental research, published in English or Russian. Exclusion criteriaincluded clinical case descriptions, non-evidence-based publications, and abstracts. Results: This review synthesizes current insights into the mechanisms underlying the association between bronchial asthma and metabolic syndrome. A conventional perspective links asthma and the syndrome through mechanical effects of abdominal adipose tissue, impacting respiratory tract resistance and volumes. Furthermore, emphasis is placed on metabolic dysregulation's role in altering proinflammatory cytokine levels and adipose tissue hormone profiles. The review also introduces the concept of a metabolic phenotype in asthma, characterizing it as an independent variant within the spectrum of "bronchial asthma – metabolic syndrome - obesity." Pathogenetic relationships involving insulin resistance, hyperinsulinemia's epithelial effects on the respiratory tract, chronic inflammation, and respiratory hyperreactivity are highlighted. Conclusions: The findings support a clinical and pathophysiological framework distinguishing a distinct "metabolic phenotype" in asthma patients. This phenotype underscores the interconnected pathogenesis involving insulin resistance, chronic inflammation, and heightened respiratory tract reactivity. Such insights contribute to advancing targeted therapeutic approaches for this subset of patients. Согласно имеющимся в настоящее время данным, бронхиальная астма (БА) и ожирение представляют собой одну из актуальнейших проблем современной медицины, значение которой приобретает мировой характер. Эпидемиологические данные позволяют констатировать значительный рост этих заболеваний в развитых странах, что диктует необходимость тщательного анализа и всестороннего изучения. Целью данного обзора являлась систематизация данных о патофизиологической и клинической взаимосвязи бронхиальной астмы и метаболического синдрома, а также роли его компонентов в формировании тяжелого течения бронхиальной астмы. Стратегия поиска: Поиск актуальной литературы проводился в базах данных PubMed, Web of Science и Кокрановском центральном регистре контролируемых испытаний до 10 мая 2024 г. Глубина поиска составила 10 лет. В ходе анализа использовались предварительно сформулированные ключевые слова на основе терминов медицинских предметных рубрик (MeSH). Критерии включения: результаты исследований, выполненных с учетом всех требований доказательной медицины; данные фундаментальных экспериментальных исследований. Поиск ограничивался работами, опубликованными на английском и русском языках. Критерии исключения: описание клинических случаев, публикации, не соответствующие требованиям доказательной медицины, а также тезисы. Результаты: В представленном обзоре систематизированы современные взгляды на механизмы формирования фенотипа бронхиальной астмы, ассоциированного с метаболическим синдромом. В классическом и наиболее упрощенном варианте связь астмы и синдрома основывается на механических эффектах жировой ткани брюшной полости на сопротивление дыхательных путей с изменением соответствующих дыхательных объемов. Представлена попытка актуализировать роль метаболического дисбаланса в уровнях провоспалительных факторов, в первую очередь цитокинов, а также гормонов жировой ткани. Кроме того, сформулирована концепция связи метаболического синдрома и бронхиальной астмы, отражающая влияние данного синдрома на варианты клинического течения заболевания. Выводы: Представленные данные...

  • Open Access

    КАРДИОМИОПАТИЯ ТАКОЦУБО В ПОСЛЕРОДОВОМ ПЕРИОДЕ: КЛИНИЧЕСКИЙ СЛУЧАЙ

    by Каражанова Л.к., Чиныбаева А.а., Орехов А.ю.

    Кардиомиопатия Такоцубо является редким клиническим синдромом, основой клинической манифестации которого является обратимая систолическая дисфункция левого желудочка. Наиболее часто дебют заболевания проявляется симптомами острой коронарной недостаточности, в ряде случаев имитируюя клиническую картину инфаркта миокарда с подъемом сегмента ST. Кардиомиопатия Такоубо наиболее часто втречается у женщин старше 70 лет. При этом описаны немногочисленные случаи развития данной патологии у беременных женщин и практически единичные – в послеродовый период. В данной статье представлен клинический случай развития кардиомиопатии Такоцубо у повторнородящей женщины в позднем послеродовом периоде и представлены наиболее актуальные данные о принципах диагностики данной патологии. Takotsubo cardiomyopathy is a rare clinical syndrome characterized by reversible systolic dysfunction of the left ventricle. The disease typically presents with symptoms of acute coronary insufficiency, often mimicking the clinical picture of myocardial infarction with ST segment elevation. Takotsubo cardiomyopathy most commonly affects women over 70 years of age. There are few documented cases of this condition occurring in pregnant women and almost none in the postpartum period. This article presents a clinical case of Takotsubo cardiomyopathy in a multiparous woman during the late postpartum period and provides current insights into the principles of diagnosing this pathology. Такоцубо кардиомиопатиясы – өте сирек кездесетін клиникалық синдром, оның клиникалық көрінісі сол жақ қарыншаның систолалық дисфункциясынаның қатымдылығына негізделген. Көбінесе аурудың басталуы жедел коронарлық жеткіліксіздік белгілерімен көрінеді, кейбір жағдайларда ST сегментінің көтерілуімен миокард инфарктісінің клиникалық көрінісіне ұқсас келеді. Такоцубо кардиомиопатиясы 70 жастан асқан әйелдерде жиі кездеседі. Сонымен қатар, жүкті әйелдерде осы патологияның дамуының бірнеше жағдайлары және босанғаннан кейінгі кезеңде сирек кездесетін жағдайлар сипатталған. Бұл мақалада босанғаннан кейінгі кеш кезеңдегі қайтадан босанған әйелдегі Такоцубо кардиомиопатиясының дамуының клиникалық жағдайы ұсынылған, сонымен қатар осы патологияны диагностикалау әдістері туралы ең заманауи деректер келтірілген.

  • Open Access

    The role of the sympathetic nervous system in resistant hypertension: pathophysiological and clinical aspects

    by A. Yu. Orekhov, L. K. Karazhanova, А. Ю. Орехов

    Resistant arterial hypertension (HTN) is a significant risk factor for cardiovascular disease and mortality. Such clinical conditions as obesity, obstructive sleep apnea and hyperaldosteronism are interrelated links of the clinical phenotype of these patients. At the same time, these conditions are interrelated by the pathophysiological basis, i.e. activity of the sympathetic nervous system. Objective. To systematize data on the role of persistent sympathetic nervous system hyperactivation in the development and progression of resistant HTN. Design and methods. We searched for clinical studies and systematic reviews in databases (PubMed, Cochrane Library) examining the role of sympathetic overdrive, as well as treatment methods for resistant HTN aimed at blocking sympathetic activation. Results. Increased activity of the sympathetic nervous system is one of the most important links in the formation of resistance to antihypertensive therapy. Moreover, it is the chronic sympathetic overdrive that unites the most common risk factors of resistant HTN, namely obstructive sleep apnea, obesity and insulin resistance, renin-angiotensin system activation, and aldosterone hyperproduction. Conclusions. The increased interest in the study of the sympathetic nervous system in recent decades has contributed to the accumulation of new data on the pathophysiological and clinical aspects of resistant HTN, as well as expanded its treatment methods by introducing into clinical practice the technique of sympathetic denervation of the renal arteries. Further study of sympathetic activation contributes to the development of new therapeutic techniques and will change the management of patients with resistant HTN.


  • Open Access

    Role of renal denervation in the treatment of arterial hypertension: a review

    by A. Yu. Orekhov, L. K. Karazhanova, А. Ю. Орехов

    Regardless of the fact that arterial hypertension is the focus of modern cardiology, resistance to therapy is still an important public health problem with adverse medical, social, and economic consequences. Aim of study: systematizing the available results of studies of the effectiveness of renal denervation in the treatment of patients with resistant AH. Search within databases (PubMed, Cochrane Library) was performed for randomized controlled studies of second-generation catheterassisted renal denervation and sham-controlled studies. We have used PRISMA protocol for preparing our paper. The neutral results of the SYMPLICITY HTN-3 study significantly weakened the interest of practical cardiology in this procedure, however recently published data from the EnligHTNed IDE, SPYRAL HTN OFF MED, and SPYRAL HTN-ON MED studies confirmed the effectiveness and safety of the technique. As the result the second-generation catheters (multielectrode catheters) used for renal denervation confirmed the effectiveness and safety of the procedure, and also expanded the technique usage beyond resistant hypertension. However, the question of the reliability of long-term effects of the procedure still remains, as well as establishing mechanisms to identify predictors of planned intervention responsiveness.